Related Experiment Video

Updated: Aug 18, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K

The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid Tumors

Cody C Gowan1, Mee Y Bartee2, Erica Flores2

  • 1Division of Nephrology and Hypertension, Mayo Clinical, Jacksonville, FL.

Journal of Immunotherapy (Hagerstown, Md. : 1997)
|December 6, 2022
PubMed

Insights

Combining T-cell immunoglobulin and mucin domain 3 (TIM3) blockade with oncolytic virotherapy (OV) eradicates established tumors. This novel immunotherapy combination shows promise for enhanced cancer treatment when single therapies are ineffective.

Area of Science:

  • Immunotherapy
  • Oncology
  • Virology

Background:

  • T-cell immunoglobulin and mucin domain 3 (TIM3) is a potential target for antibody-based cancer immunotherapy.
  • The combination efficacy of TIM3 blockade with other treatment modalities requires further investigation.

Purpose of the Study:

  • To investigate the combined efficacy of TIM3 blockade and myxoma virus-based oncolytic virotherapy (OV) in cancer treatment.
  • To determine if OV can enhance the immunotherapeutic potential of TIM3 blockade.

Main Methods:

  • Combination therapy involving TIM3 blockade and myxoma virus-based OV.
  • Assessment of antitumor immune response and tumor microenvironment modulation.

Main Results:

  • Myxoma virus-based OV effectively initiates an antitumor immune response.
  • TIM3 blockade shifts the tumor microenvironment towards a proinflammatory state.
  • The combination therapy completely eradicated established tumors, outperforming monotherapies.

Conclusions:

  • Oncolytic virotherapy (OV) can enhance the efficacy of TIM3 blockade.
  • This combination therapy represents a promising strategy for aggressive, combinatorial cancer immunotherapy regimens.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.1K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.6K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
629
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K